Skip to content

Quantifying stimulus evoked electroencephalographic variability in mild dementia

A pilot study designed to compare differences in stimulus evoked electroencephalographic variability between participants assessed to be cognitively normal and participants diagnosed with mild dementia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12623000285651
Acronym
EEGVID
Enrollment
8
Registered
2023-03-16
Start date
2023-09-05
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study will assess a potential new method for the early detection of changes in brain function, referred to as Brain Function Fingerprinting or BFF. BFF involves the recording of brain waves (electroencephalogram or EEG) in response to sequences of simple visual or auditory stimuli and analysing the variability of their response. Changes in the variability of the response are hypothesised to indicate changes in brain function. We wish to test the hypothesis that BFF can detect differences between cognitively normal participants and participants suffering from mild dementia due to possible or probable Alzheimer’s Disease. The study will aim to recruit, over 12 months, a maximum of 24 participants suffering from mild dementia due to possible or probable Alzheimer’s Disease, and 24 of their cognitively normal partners, from the St George’s Hospital. The partners' cognitively normal status will be confirmed by comprehensive clinical evaluation.

Interventions

Twenty four participants diagnosed with mild dementia due to possible or probable Alzheimer's disease (MDAD), and 24 age matched controls (CN), will be recruited through a Cognitive Dementia and Memory Service (CADMS) Clinic. All participants will have their time locked, 64 channel electroencephalogram (EEG), recorded in response to three simple cognitive tasks delivered by a laptop computer connected to headphones: an active visual semantic priming task, a passive visual memory repetition pri

Twenty four participants diagnosed with mild dementia due to possible or probable Alzheimer's disease (MDAD), and 24 age matched controls (CN), will be recruited through a Cognitive Dementia and Memory Service (CADMS) Clinic. All participants will have their time locked, 64 channel electroencephalogram (EEG), recorded in response to three simple cognitive tasks delivered by a laptop computer connected to headphones: an active visual semantic priming task, a passive visual memory repetition priming task and an active three level auditory oddball task. The active visual semantic priming task requires participants to indicate via button press whether a sequential pair of briefly presented images are semantically related. The passive visual memory repetition task involves the participant viewing a sequence of images that may be novel or repeated once or twice. The active three level auditory oddball task requires participants to listen to a sequence of randomly presented tones (drawn from one of three frequencies) and to indicate via button press when a defined target tone is heard. EEG recordings will be performed by trained research staff. Tasks will be run consecutively in random order, with 2 minutes each of eyes-closed and eyes-open resting EEG recorded at the beginning of the testing session. The total testing time will be approximately 60 minutes.

Sponsors

St Vincent's Hospital Melbourne
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Male and female participants 60 years or older English speaking and basic levels of literacy in order to be able to give informed consent and to follow all instructions Normal or corrected hearing and vision CN group: Formally assessed to be cognitively normal by CADMS Neuropsychiatrist MDAD group: Formal diagnosis by CADMS Neuropsychiatrist of possible or probable Alzheimer's Disease; Mild dementia as defined by Clinical Dementia Rating score of 0.5 - 1, Global Deterioration Scale score of 4, and Min-mental Status Examination score of 18 - 23

Exclusion criteria

Colour blindness Any history of illness affecting cognitive function e.g., vitamin B12 deficiency, hypothyroidism, significant psychiatric disorders (such as major depression or schizophrenia), neurodegenerative disorders, ischaemic stroke, epilepsy, brain tumour, significant head trauma Any episodes of unexplained loss of consciousness History of substance or alcohol abuse Taking an acetylcholinesterase inhibitor, or any other agent demonstrated to affect cognitive function, within the last 3 months

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026